6,229 Shares in Astera Labs, Inc. $ALAB Purchased by Private Advisory Group LLC

Private Advisory Group LLC purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) during the third quarter, HoldingsChannel.com reports. The firm purchased 6,229 shares of the company’s stock, valued at approximately $1,220,000.

A number of other large investors have also bought and sold shares of ALAB. Royal Bank of Canada grew its holdings in shares of Astera Labs by 167.3% during the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares during the last quarter. AQR Capital Management LLC raised its stake in shares of Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after acquiring an additional 7,756 shares during the last quarter. Empowered Funds LLC lifted its position in shares of Astera Labs by 917.3% during the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares in the last quarter. Chicago Partners Investment Group LLC acquired a new stake in shares of Astera Labs in the second quarter valued at approximately $166,000. Finally, Ethic Inc. lifted its holdings in Astera Labs by 234.0% during the 2nd quarter. Ethic Inc. now owns 15,811 shares of the company’s stock worth $1,439,000 after buying an additional 11,077 shares in the last quarter. 60.47% of the stock is currently owned by institutional investors.

Astera Labs Trading Down 2.2%

Shares of Astera Labs stock opened at $129.68 on Monday. Astera Labs, Inc. has a 12 month low of $47.13 and a 12 month high of $262.90. The company has a market capitalization of $21.90 billion, a PE ratio of 106.30, a PEG ratio of 2.55 and a beta of 1.51. The stock’s fifty day simple moving average is $160.40 and its 200 day simple moving average is $174.33.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. The business had revenue of $270.58 million for the quarter, compared to analysts’ expectations of $249.46 million. Astera Labs had a return on equity of 16.87% and a net margin of 25.70%.Astera Labs’s revenue for the quarter was up 91.8% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.37 EPS. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts predict that Astera Labs, Inc. will post 0.34 EPS for the current fiscal year.

Key Stories Impacting Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Zacks highlights rising AI connectivity demand and Astera’s expansion of NVLink and Scorpio product lines, framing a multiyear market opportunity that could support revenue growth. ALAB Rides on Strong Connectivity Demand
• Positive Sentiment: Seeking Alpha notes strong fundamentals: revenue more than doubled YoY, very healthy free cash flow margins (>30%), roughly $1.19B cash and no debt — giving Astera flexibility to invest or absorb near‑term headwinds. The Great Astera Labs Reset
• Positive Sentiment: Recent quarterly results beat expectations (EPS and revenue) and management set Q1 2026 guidance; continued demand for high‑speed interconnects supports the growth narrative. Earnings & Guidance
• Neutral Sentiment: Reported short-interest data is effectively immaterial/odd (reported as zero), so short‑pressure does not explain intraday moves — it’s a non‑factor for current trading dynamics. Short Interest Report
• Negative Sentiment: CEO sale: Jitendra Mohan sold 94,971 shares at ~$123.81 (~$11.8M), trimming his stake by ~6.14% — a sizeable single‑day sale that can be viewed negatively by investors. CEO Form 4
• Negative Sentiment: COO sale: Sanjay Gajendra sold 94,971 shares at ~$123.81 (~$11.8M), reducing his holding by ~5.84% — another large insider disposition on the same date that amplifies concern. COO Form 4
• Negative Sentiment: CFO sale: Michael Truett Tate sold 12,001 shares at ~$123.81 (~$1.49M), lowering his stake by ~5.88% — adds to the cluster of senior‑level selling. CFO Form 4
• Negative Sentiment: General Counsel sale: Philip Mazzara sold 4,849 shares at ~$123.80 (~$600k), a smaller but concurrent insider reduction — multiple senior officers selling the same day increases perceived signal of liquidity taking or diversification. GC Form 4

Insiders Place Their Bets

In related news, General Counsel Philip Mazzara sold 4,849 shares of the stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.80, for a total transaction of $600,306.20. Following the completion of the transaction, the general counsel directly owned 138,084 shares in the company, valued at approximately $17,094,799.20. This trade represents a 3.39% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Manuel Alba sold 150,000 shares of the stock in a transaction on Monday, December 1st. The stock was sold at an average price of $166.18, for a total transaction of $24,927,000.00. Following the transaction, the director owned 1,574,498 shares of the company’s stock, valued at $261,650,077.64. The trade was a 8.70% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold a total of 389,792 shares of company stock worth $56,013,809 in the last ninety days. 12.50% of the stock is owned by insiders.

Analyst Upgrades and Downgrades

Several analysts have weighed in on the company. TD Cowen reissued a “hold” rating on shares of Astera Labs in a report on Wednesday, November 5th. Wall Street Zen downgraded Astera Labs from a “buy” rating to a “hold” rating in a research note on Tuesday, November 11th. BNP Paribas Exane began coverage on Astera Labs in a research report on Thursday, November 20th. They issued an “outperform” rating on the stock. Raymond James Financial began coverage on Astera Labs in a report on Friday, November 21st. They issued a “hold” rating for the company. Finally, Citigroup cut their target price on Astera Labs from $275.00 to $250.00 and set a “buy” rating on the stock in a research note on Wednesday, February 11th. Fourteen research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $192.89.

Astera Labs Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.